Department of Cardiac Surgery, Vanderbilt Heart & Vascular Institute, Nashville, TN, USA.
J Thorac Cardiovasc Surg. 2011 Dec;142(6):1423-9. doi: 10.1016/j.jtcvs.2010.12.030. Epub 2011 Apr 9.
We propose a simplified anatomic classification for pulmonary emboli that algorithmically differentiates those who might be best treated with surgical pulmonary embolectomy (type A) from those best treated medically (type B). We hypothesized that patients with type A pulmonary emboli treated with immediate surgical embolectomy demonstrate superior long-term survival compared with patients with type A pulmonary emboli treated medically.
Patients admitted between 2002 and 2008 with a diagnosis of pulmonary emboli made based on computed tomographic angiographic imaging (n = 779) were analyzed. Computed tomographic angiographic images were reviewed in a blind fashion, and anatomic classification of emboli was made. Patients with central thrombus, defined by location medial to the lateral mediastinal boundaries (ie, involving the main, primary, or both branch pulmonary arteries), were classified as having type A pulmonary emboli (n = 107), whereas those with peripheral pulmonary emboli located beyond these boundaries were classified as having type B pulmonary emboli (n = 672). Four patients with type A pulmonary emboli treated with catheter embolectomy were excluded from the analysis.
Of the 103 patients with type A pulmonary emboli, 15 (14%) were treated with immediate surgical pulmonary embolectomy, and 88 (85%) were treated medically. Patients with type A pulmonary emboli treated surgically had similar 30-day mortality compared with those treated medically (13% vs 17%, P = .532). At a mean of 24 ± 18 months' follow-up (range, 1-82 months), survival at 1, 3, and 5 years for patients with type A pulmonary emboli treated surgically was significantly better than that in the patients with type A pulmonary emboli treated medically (P = .0001).
For patients with type A pulmonary emboli, immediate surgical intervention appears to offer superior midterm survival compared with medical treatment alone. Although the medical and surgical groups were substantially different and the differences might have affected survival, this simplified classification for pulmonary emboli might help direct optimal treatment strategies.
我们提出了一种简化的肺栓塞解剖分类方法,该方法可以通过算法将那些最适合接受手术肺动脉血栓切除术(A型)治疗的患者与那些最适合接受药物治疗的患者(B 型)区分开来。我们假设,接受立即手术取栓治疗的 A 型肺栓塞患者比接受药物治疗的 A 型肺栓塞患者具有更好的长期生存。
对 2002 年至 2008 年间因计算机断层血管造影(CTA)成像诊断为肺栓塞而入院的 779 例患者进行分析。对 CTA 图像进行盲法复查,并进行栓塞解剖分类。位于外侧纵隔边界内侧的中央血栓(即累及主、一级或两者的肺动脉分支)患者被归类为 A 型肺栓塞(n=107),而位于这些边界之外的周围性肺栓塞患者被归类为 B 型肺栓塞(n=672)。4 例接受导管取栓术治疗的 A 型肺栓塞患者被排除在分析之外。
103 例 A 型肺栓塞患者中,15 例(14%)接受立即手术肺动脉血栓切除术治疗,88 例(85%)接受药物治疗。接受手术治疗的 A 型肺栓塞患者的 30 天死亡率与接受药物治疗的患者相似(13%vs17%,P=0.532)。在平均 24±18 个月的随访(范围 1-82 个月)中,接受手术治疗的 A 型肺栓塞患者的 1、3 和 5 年生存率明显优于接受药物治疗的患者(P=0.0001)。
对于 A 型肺栓塞患者,立即手术干预似乎比单独药物治疗提供更好的中期生存。尽管医疗和手术组之间存在明显差异,这些差异可能影响生存,但这种简化的肺栓塞分类方法可能有助于指导最佳治疗策略。